Skip to content Skip to footer
Close

M.D.

Dr. Luis Jorge Jacinto

Dr. Luis Jorge Jacinto

Biography

Dr. Luis Jorge Jacinto received his academic degree from the Faculdade de Medicina de Lisboa in 1990. He is the Director of one Adult Rehabilitation Service (68 beds for inpatient neurorehabilitation) since 2009 and in charge of the Gait Laboratory (since 2000), at the Centro de Medicina de Reabilitação de Alcoitão, Alcabideche, Portugal.

He started the Botulinum Toxin Clinic at the Centro de Medicina de Reabilitação in 2000. During 2000-2015, he was a permanent PM&R consultant of the Associação de Paralisia Cerebral de Lisboa (Lisbon Association of Cerebral Palsy). He has been mostly dedicated to neurological rehabilitation and particularly the treatment of spasticity – evaluation treatment and follow-up of neurologic patients treated with botulinum toxin, having authored/co-authored several publications.

He was the Deputy Clinical Director at Centro de Medicina de Reabilitação de Alcoitão (2006-2009).

Dr. Jacinto has had several teaching experiences at the Faculdade de Medicina da Universidade de Lisboa, Escola Superior de Saude de Alcoitao, Instituto Superior Técnico – Universidade Técnica de Lisboa, Universidade Nova de Lisboa and Universidade Autónoma de Lisboa.

He teaches courses at national and international level for specialists and residents in physical medicine and rehabilitation, concerning “gait analysis”, “use of botulinum toxin within the global management of spasticity”, “patient centered Goal Setting”, “outcomes in PM&R”, “Patient centered multidisciplinary team approach in Neuro-rehabilitation”.

He is a member of several scientific societies: SPMFR – Sociedade Portuguesa de Medicina Física e de Reabilitação, Sociedad Española de Neuro- Rehabilitación, European Society of Physical Medicine and Rehabilitation, Internacional Society of Physical and Rehabilitation Medicine, World Federation of Neurorehabilitation and Iberia Society of Biomechanics in Rehabilitation- SIBRehab.He is also a member of the PM&R board of the College of Physicians of Portugal.

Address: Portugal

© 2025 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.